CD79b-19 CAR T
/ Massachusetts General Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 29, 2024
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Marcela V. Maus, M.D.,Ph.D. | Trial completion date: Oct 2027 ➔ Jan 2028 | Trial primary completion date: Oct 2025 ➔ Jan 2027
CAR T-Cell Therapy • Trial completion date • Trial primary completion date • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Indolent Lymphoma • Lymphoma • Mantle Cell Lymphoma • Marginal Zone Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD79B
December 15, 2023
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: Marcela V. Maus, M.D.,Ph.D. | Not yet recruiting ➔ Recruiting | Initiation date: Feb 2024 ➔ Oct 2023
CAR T-Cell Therapy • Enrollment open • Trial initiation date • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Indolent Lymphoma • Lymphoma • Mantle Cell Lymphoma • Marginal Zone Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • CD79B
1 to 2
Of
2
Go to page
1